FDA advisory committees
Executive Summary
Non-voting industry representatives will be added to all Center for Biologics Evaluation & Research and Center for Drug Evaluation & Research advisory committees. The FDA Modernization Act requires industry representatives for newly formed advisory committees. "Although not required for existing committees," FDA said it would add non-voting representatives "to keep within the spirit of FDAMA." An Aug. 16 Federal Register notice requests nominations